Hubungan Kadar Procalcitonin dengan Jenis Bakteri Penyebab Infeksi pada Sepsis di RSUP H. Adam Malik Tahun 2014
30
DAFTAR PUSTAKA
Artero, A., Zaragoza, R. & Nogueira, J. M., 2012. Edpidemiology of Severe
Sepsis and Septic Shock. In: D. R. Fernandez, ed. Understanding A
Serious Killer. Croatia: InTech Europe, pp. 1-20.
Charles, P. E. et al., 2008. Serum procalcitonin elevation in critically ill patients at
the onset of bacteremia cause by either gram negative or gram positive
bacteria. BMC Infectious Diseases, pp. 1-8.
Dellinger, R. P. et al., 2013. International Guidelines for Management of Severe
Sepsis and Septic Shock: 2012. Surviving Sepsis Campaign, 41(2), pp.
580-586.
Meisner, M., 2010. Procalcitonin - Biochemistry and Clinical Diagnosis. 1st ed.
Dresden: UNI-MED.
Morse, S. A., 2007. Cell Structure, Classification of Bacteria. In: G. F. Brooks, J.
S. Butel, K. C. Caroll & S. A. Morse, eds. Medical Microbiology. New
York: The McGraw-Hill Companies, pp. 39-46.
Nakajima, A. et al., 2014. Clinical Utility of Procalcitonin as a Marker of Sepsis:
A Potential Predictor of Causative Pathogens. Internal Medicine, Volume
53, pp. 1499-1500.
Napitupulu, H. H., 2010. Sepsis. Anestesia & Critical Care, 28(3), pp. 50-57.
Nargis, W., Ibrahim, M. & Ahamed, B. U., 2014. Procalcitonin versus C-reactive
protein: Usefulness as biomarker of sepsis in ICU patient. International
Journal of Critical Illness and Injury Science, 4(3), pp. 195-199.
Perman, S. M., Goyal, M. & Gaieski, D. F., 2012. Initial Emergency Department
Diagnosis and Management of Adult Patients with Severe Sepsis adn
Septic Shock. Perman et al. Scandinavian Journal of Trauma,
Resucitation and Emergency Medicine 2012, 20(41), pp. 1-11.
Protocol Molecular Cell Physiology, 2001. Gram Stain Technique. [Online]
Available
at:
http://www.falw.vu/~microb/Protocols/General_protocols/GramKleuring.pdf [Accessed 03 June 2015].
Reinhart, K., Bauer, M., Rieddermann, N. C. & Hartog, C. S., 2012. New
Approaches to Sepsis: Molecular Diagnostics and Biomarkers. Clinical
Microbiology Reviews, 25(4), pp. 609-634.
Universitas Sumatera Utara
31
Shah, B. A. & Padbury, J. F., 2014. Neonatal Sepsis - An Old Problem with New
Insights. Virulence, 5(1), pp. 170-174.
Shin, Y. -J., Ki, M. & Foxman, B., 2013. Epidemiology of neonatal sepsis in
South Korea. NIH Public Access, pp. 1-7.
Simonsen, K. A., Anderson-Berry, A. L., Delair, S. F. & Davies, H. D., 2014.
Early-Onset Neonatal Sepsis. Clinical Microbiology Reviews, 27(1), pp.
22-30.
Stearns-Kurosawa, D. J. et al., 2013. The Pathogenesis of Sepsis. NIH Public
Access, pp. 1-3.
Taljaard, J., 2010. Sepsis: at-risk patinets, clinical manifestattions and
management. CME, 28(6), pp. 260-264.
Tazbir, J., 2012. Early Recognition and Treatment of Sepsis in the MedicalSurgical Setting. CNE SERIES, 21(4), pp. 205-209.
Uthman, E. O., 1997. Bacterial Sepsis. pp. 1-8.
Universitas Sumatera Utara
DAFTAR PUSTAKA
Artero, A., Zaragoza, R. & Nogueira, J. M., 2012. Edpidemiology of Severe
Sepsis and Septic Shock. In: D. R. Fernandez, ed. Understanding A
Serious Killer. Croatia: InTech Europe, pp. 1-20.
Charles, P. E. et al., 2008. Serum procalcitonin elevation in critically ill patients at
the onset of bacteremia cause by either gram negative or gram positive
bacteria. BMC Infectious Diseases, pp. 1-8.
Dellinger, R. P. et al., 2013. International Guidelines for Management of Severe
Sepsis and Septic Shock: 2012. Surviving Sepsis Campaign, 41(2), pp.
580-586.
Meisner, M., 2010. Procalcitonin - Biochemistry and Clinical Diagnosis. 1st ed.
Dresden: UNI-MED.
Morse, S. A., 2007. Cell Structure, Classification of Bacteria. In: G. F. Brooks, J.
S. Butel, K. C. Caroll & S. A. Morse, eds. Medical Microbiology. New
York: The McGraw-Hill Companies, pp. 39-46.
Nakajima, A. et al., 2014. Clinical Utility of Procalcitonin as a Marker of Sepsis:
A Potential Predictor of Causative Pathogens. Internal Medicine, Volume
53, pp. 1499-1500.
Napitupulu, H. H., 2010. Sepsis. Anestesia & Critical Care, 28(3), pp. 50-57.
Nargis, W., Ibrahim, M. & Ahamed, B. U., 2014. Procalcitonin versus C-reactive
protein: Usefulness as biomarker of sepsis in ICU patient. International
Journal of Critical Illness and Injury Science, 4(3), pp. 195-199.
Perman, S. M., Goyal, M. & Gaieski, D. F., 2012. Initial Emergency Department
Diagnosis and Management of Adult Patients with Severe Sepsis adn
Septic Shock. Perman et al. Scandinavian Journal of Trauma,
Resucitation and Emergency Medicine 2012, 20(41), pp. 1-11.
Protocol Molecular Cell Physiology, 2001. Gram Stain Technique. [Online]
Available
at:
http://www.falw.vu/~microb/Protocols/General_protocols/GramKleuring.pdf [Accessed 03 June 2015].
Reinhart, K., Bauer, M., Rieddermann, N. C. & Hartog, C. S., 2012. New
Approaches to Sepsis: Molecular Diagnostics and Biomarkers. Clinical
Microbiology Reviews, 25(4), pp. 609-634.
Universitas Sumatera Utara
31
Shah, B. A. & Padbury, J. F., 2014. Neonatal Sepsis - An Old Problem with New
Insights. Virulence, 5(1), pp. 170-174.
Shin, Y. -J., Ki, M. & Foxman, B., 2013. Epidemiology of neonatal sepsis in
South Korea. NIH Public Access, pp. 1-7.
Simonsen, K. A., Anderson-Berry, A. L., Delair, S. F. & Davies, H. D., 2014.
Early-Onset Neonatal Sepsis. Clinical Microbiology Reviews, 27(1), pp.
22-30.
Stearns-Kurosawa, D. J. et al., 2013. The Pathogenesis of Sepsis. NIH Public
Access, pp. 1-3.
Taljaard, J., 2010. Sepsis: at-risk patinets, clinical manifestattions and
management. CME, 28(6), pp. 260-264.
Tazbir, J., 2012. Early Recognition and Treatment of Sepsis in the MedicalSurgical Setting. CNE SERIES, 21(4), pp. 205-209.
Uthman, E. O., 1997. Bacterial Sepsis. pp. 1-8.
Universitas Sumatera Utara